BARD C R INC /NJ/
Healthcare · Surgical & Medical Instruments & Apparatus · NJ · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $873.5M | $819.7M | $3.32B | $3.05B | $2.96B | $2.90B |
| Operating income | — | — | — | — | — | — |
| Net income | $116.2M | $139.8M | $294.5M | $689.8M | $138.7M | $131.9M |
| Total assets | $5.31B | $4.84B | $5.09B | $5.04B | $4.15B | $3.93B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $1.68B | $1.46B | $1.80B | $2.09B | $1.93B | $1.62B |
| EPS (diluted) | $1.54 | $1.82 | $3.76 | $8.39 | $6.16 | $3.69 |
| Shares out. | 73.7M | 74.3M | 77.6M | 81.8M | 84.1M | 85.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- —
- Net margin
- 13.3%
- Return on equity
- 6.9%
- Return on assets
- 2.2%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $22.72
- Revenue growth (YoY)
- 6.6%
- Net income growth (YoY)
- −16.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Accruals / assets
- −8.1%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 good- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventDec 29, 2017
- Results of operationsOct 25, 2017
- Shareholder vote · Other material eventAug 8, 2017
- Entered a material agreement · Other material eventJul 28, 2017
- Results of operationsJul 27, 2017
- Other material eventJun 9, 2017
- Entered a material agreementMay 23, 2017
- Entered a material agreement · Results of operations · Director / officer change · Other material eventApr 24, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.